These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17714874)

  • 1. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts.
    Osawa M; Yamamoto Y; Munesue S; Murakami N; Sakurai S; Watanabe T; Yonekura H; Uchigata Y; Iwamoto Y; Yamamoto H
    Biochim Biophys Acta; 2007 Oct; 1770(10):1468-74. PubMed ID: 17714874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant.
    Park SJ; Kleffmann T; Hessian PA
    J Biol Chem; 2011 Jun; 286(24):21384-92. PubMed ID: 21511948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells.
    Yamamoto Y; Yonekura H; Watanabe T; Sakurai S; Li H; Harashima A; Myint KM; Osawa M; Takeuchi A; Takeuchi M; Yamamoto H
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S30-40. PubMed ID: 17462779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products.
    Valencia JV; Mone M; Koehne C; Rediske J; Hughes TE
    Diabetologia; 2004 May; 47(5):844-52. PubMed ID: 15127201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
    Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
    Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
    Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
    Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    C RC; Lukose B; Rani P
    PLoS One; 2020; 15(10):e0225487. PubMed ID: 33119615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli.
    Wilton R; Yousef MA; Saxena P; Szpunar M; Stevens FJ
    Protein Expr Purif; 2006 May; 47(1):25-35. PubMed ID: 16510295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
    Schmidt AM; Hori O; Chen JX; Li JF; Crandall J; Zhang J; Cao R; Yan SD; Brett J; Stern D
    J Clin Invest; 1995 Sep; 96(3):1395-403. PubMed ID: 7544803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
    Boulanger E; Wautier MP; Wautier JL; Boval B; Panis Y; Wernert N; Danze PM; Dequiedt P
    Kidney Int; 2002 Jan; 61(1):148-56. PubMed ID: 11786095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
    Opatrna S; Popperlova A; Kalousová M; Zima T
    Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Shen L
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.
    Ma W; Lee SE; Guo J; Qu W; Hudson BI; Schmidt AM; Barile GR
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1355-61. PubMed ID: 17325184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of age and uncoupling protein-2 in oxidative stress, RAGE/AGE interaction and inflammatory liver injury.
    Kuhla A; Trieglaff C; Vollmar B
    Exp Gerontol; 2011 Nov; 46(11):868-76. PubMed ID: 21820503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of advanced glycation end-products in diabetic and inherited canine cataracts.
    Bras ID; Colitz CM; Kusewitt DF; Chandler H; Lu P; Gemensky-Metzler AJ; Wilkie DA
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):249-57. PubMed ID: 16896921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
    Ishibashi Y; Yamagishi S; Matsui T; Ohta K; Tanoue R; Takeuchi M; Ueda S; Nakamura K; Okuda S
    Metabolism; 2012 Aug; 61(8):1067-72. PubMed ID: 22386936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.